Physicians' use of electronic heath records did little to improve the quality of care for diabetes patients, according to a study in the Annals of Family Medicine.
Using data for nearly 800 patients treated at 42 physician practices over a three-year period, researchers from Robert Wood Johnson Medical School at the University of Medicine & Dentistry of New Jersey found lower-quality care at the study's baseline at practices using EHR systems, and they found no link between EHR use and improved adherence to clinical guidelines for processes-of-care and recommended treatments.
Read the full story: http://hcp.lv/J6hWmi
Source: ModernHealthcare.com
Also, they determined that patients treated at practices that did not use an EHR system had a greater likelihood of meeting outcomes-based health targets, including blood pressure and A1c levels, at two-year follow-up appointments.
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer
March 28th 2024This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
CMS is highly likely to negotiate the price of the obesity medication semaglutide in the coming years; many health care providers are trying to determine whether their cyberattack insurance will help cover their losses after the Change Healthcare hack; the US life expectancy increased for the first time in 2 years.
Read More